2024-20999. Medical Devices; Therapeutic Devices; Classification of the Pediatric Continuous Renal Replacement Therapy System
Table 1—Pediatric Continuous Renal Replacement Therapy System Risks and Mitigation Measures
Identified risks to health Mitigation measures Adverse tissue reaction Biocompatibility evaluation, Pyrogenicity testing, and Non-clinical performance testing. Death Labeling, Clinical performance testing, and Usability testing. Infection Labeling, Reprocessing validation, Pyrogenicity testing, Shelf life testing, and Usability testing. Inadequate or incomplete treatment Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis. Clearance of essential blood substances or medications Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis. Blood loss or blood cell destruction Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; and Software verification, validation, and hazard analysis. Thermal injury Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis. Blood leak into the dialysis fluid Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; and Software verification, validation, and hazard analysis. Fluid imbalance Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; and Software verification, validation, and hazard analysis. Air embolism Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis. Fluid pump(s) reversal resulting in air infusion via the arterial bloodline Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software, verification, validation, and hazard analysis. Electrical shock Electrical safety testing. Electromagnetic interference with other devices/equipment Electromagnetic compatibility (EMC) testing.
Document Information
- Effective Date:
- 9/16/2024
- Published:
- 09/16/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final amendment; final order.
- Document Number:
- 2024-20999
- Dates:
- This order is effective September 16, 2024. The classification was applicable on April 29, 2020.
- Pages:
- 75493-75497 (5 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-4082
- Topics:
- Medical devices
- PDF File:
- 2024-20999.pdf
- CFR: (1)
- 21 CFR 876